Literature DB >> 26547058

Nonparametric association analysis of bivariate left-truncated competing risks data.

Yu Cheng1, Pao-Sheng Shen2, Zhumin Zhang3, HuiChuan J Lai4.   

Abstract

We develop time-varying association analyses for onset ages of two lung infections to address the statistical challenges in utilizing registry data where onset ages are left-truncated by ages of entry and competing-risk censored by deaths. Two types of association estimators are proposed based on conditional cause-specific hazard function and cumulative incidence function that are adapted from unconditional quantities to handle left truncation. Asymptotic properties of the estimators are established by using the empirical process techniques. Our simulation study shows that the estimators perform well with moderate sample sizes. We apply our methods to the Cystic Fibrosis Foundation Registry data to study the relationship between onset ages of Pseudomonas aeruginosa and Staphylococcus aureus infections.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Cause-specific hazard function; Conditional quantity; Cumulative incidence function; Empirical process; Left truncation; Lung infection

Mesh:

Year:  2015        PMID: 26547058      PMCID: PMC5720874          DOI: 10.1002/bimj.201400126

Source DB:  PubMed          Journal:  Biom J        ISSN: 0323-3847            Impact factor:   2.207


  8 in total

1.  Non-parametric estimation of bivariate failure time associations in the presence of a competing risk.

Authors:  Karen Bandeen-Roche; Jing Ning
Journal:  Biometrika       Date:  2008-03-01       Impact factor: 2.445

2.  Nonparametric association analysis of exchangeable clustered competing risks data.

Authors:  Yu Cheng; Jason P Fine; Michael R Kosorok
Journal:  Biometrics       Date:  2008-05-11       Impact factor: 2.571

3.  Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition.

Authors:  M R Kosorok; L Zeng; S E West; M J Rock; M L Splaingard; A Laxova; C G Green; J Collins; P M Farrell
Journal:  Pediatr Pulmonol       Date:  2001-10

Review 4.  Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy.

Authors:  Geraint B Rogers; Lucas R Hoffman; Marvin Whiteley; Thomas W V Daniels; Mary P Carroll; Kenneth D Bruce
Journal:  Trends Microbiol       Date:  2010-06-01       Impact factor: 17.079

5.  Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.

Authors:  Patrick A Flume; Brian P O'Sullivan; Karen A Robinson; Christopher H Goss; Peter J Mogayzel; Donna Beth Willey-Courand; Janet Bujan; Jonathan Finder; Mary Lester; Lynne Quittell; Randall Rosenblatt; Robert L Vender; Leslie Hazle; Kathy Sabadosa; Bruce Marshall
Journal:  Am J Respir Crit Care Med       Date:  2007-08-29       Impact factor: 21.405

6.  Association between initial disease presentation, lung disease outcomes, and survival in patients with cystic fibrosis.

Authors:  HuiChuan J Lai; Yu Cheng; Hyungjun Cho; Michael R Kosorok; Philip M Farrell
Journal:  Am J Epidemiol       Date:  2004-03-15       Impact factor: 4.897

7.  The changing epidemiology of cystic fibrosis.

Authors:  S C FitzSimmons
Journal:  J Pediatr       Date:  1993-01       Impact factor: 4.406

Review 8.  Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations.

Authors:  Patrick A Flume; Peter J Mogayzel; Karen A Robinson; Christopher H Goss; Randall L Rosenblatt; Robert J Kuhn; Bruce C Marshall
Journal:  Am J Respir Crit Care Med       Date:  2009-09-03       Impact factor: 21.405

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.